Brain Advance Access originally published online on August 25, 2004
Brain 2004 127(12):2572-2583; doi:10.1093/brain/awh287
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain Vol. 127 No. 12 © Guarantors of Brain 2004; all rights reserved
Review Article |
Neuropathological findings in autism
1 Rudolf Magnus Institute of Neuroscience, Department of Child and Adolescent Psychiatry, University Medical Center Utrecht, Utrecht, 2 European Graduate School of Neuroscience (EURON), 3 Department of Psychiatry and Neuropsychology, Division of Cellular Neuroscience, University of Maastricht, Maastricht, The Netherlands, 4 Department of Anatomy and Cell Biology, RWTH Aachen University, Aachen, Germany and 5 Department of Neuroscience and Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, NY, USA
Correspondence to: Saskia Palmen, MD, Department of Child and Adolescent Psychiatry, HP A01.468, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands E-mail: s.palmen{at}azu.nl
Autism is currently viewed as a largely genetically determined neurodevelopmental disorder, although its underlying biological causes remain to be established. In this review, we examine the available neuropathological literature on autism and discuss the findings that have emerged. Classic neuropathological observations are rather consistent with respect to the limbic system (nine of 14 studied cases showed increased cell packing density and smaller neuronal size), the cerebellum (21 of 29 studied cases showed a decreased number of Purkinje cells, and in all of five cases that were examined for age-related morphological alterations, these changes were found in cerebellar nuclei and inferior olive) and the cerebral cortex (>50% of the studied cases showed features of cortical dysgenesis). However, all reported studies had to contend with the problem of small sample sizes, the use of quantification techniques not free of bias and assumptions, and high percentages of autistic subjects with comorbid mental retardation (at least 70%) or epilepsy (at least 40%). Furthermore, data from the limbic system and on age-related changes lack replication by independent groups. It is anticipated that future neuropathological studies hold great promise, especially as new techniques such as design-based stereology and gene expression are increasingly implemented and combined, larger samples are analysed, and younger subjects free of comorbidities are investigated.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Maussion, J. Carayol, A.-M. Lepagnol-Bestel, F. Tores, Y. Loe-Mie, U. Milbreta, F. Rousseau, K. Fontaine, J. Renaud, J.-M. Moalic, et al. Convergent evidence identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a susceptibility gene for autism Hum. Mol. Genet., August 15, 2008; 17(16): 2541 - 2551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. J. van Kooten, S. J. M. C. Palmen, P. von Cappeln, H. W. M. Steinbusch, H. Korr, H. Heinsen, P. R. Hof, H. van Engeland, and C. Schmitz Neurons in the fusiform gyrus are fewer and smaller in autism Brain, April 1, 2008; 131(4): 987 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Craig, S. H. Zaman, E. M. Daly, W. J. Cutter, D. M. W. Robertson, B. Hallahan, F. Toal, S. Reed, A. Ambikapathy, M. Brammer, et al. Women with autistic-spectrum disorder: magnetic resonance imaging study of brain anatomy The British Journal of Psychiatry, September 1, 2007; 191(3): 224 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Campbell, J. S. Sutcliffe, P. J. Ebert, R. Militerni, C. Bravaccio, S. Trillo, M. Elia, C. Schneider, R. Melmed, R. Sacco, et al. From the Cover: A genetic variant that disrupts MET transcription is associated with autism PNAS, November 7, 2006; 103(45): 16834 - 16839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Friedlander, J. A. Yagiela, V. I. Paterno, and M. E. Mahler The neuropathology, medical management and dental implications of autism. J Am Dent Assoc, November 1, 2006; 137(11): 1517 - 1527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Laumonnier, S. Roger, P. Guerin, F. Molinari, R. M'Rad, D. Cahard, A. Belhadj, M. Halayem, A. M. Persico, M. Elia, et al. Association of a Functional Deficit of the BKCa Channel, a Synaptic Regulator of Neuronal Excitability, With Autism and Mental Retardation Am J Psychiatry, September 1, 2006; 163(9): 1622 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Petropoulos, S. D. Friedman, D.W.W. Shaw, A. A. Artru, G. Dawson, and S. R. Dager Gray matter abnormalities in autism spectrum disorder revealed by T2 relaxation. Neurology, August 22, 2006; 67(4): 632 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ashwood, S. Wills, and J. Van de Water The immune response in autism: a new frontier for autism research J. Leukoc. Biol., July 1, 2006; 80(1): 1 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Friedman, D. W. W. Shaw, A. A. Artru, G. Dawson, H. Petropoulos, and S. R. Dager Gray and White Matter Brain Chemistry in Young Children With Autism. Arch Gen Psychiatry, July 1, 2006; 63(7): 786 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. DiCicco-Bloom, C. Lord, L. Zwaigenbaum, E. Courchesne, S. R. Dager, C. Schmitz, R. T. Schultz, J. Crawley, and L. J. Young The developmental neurobiology of autism spectrum disorder. J. Neurosci., June 28, 2006; 26(26): 6897 - 6906. [Full Text] [PDF]
|
|